Connect with us

Hi, what are you looking for?

Stock

ECB to apply Danish compromise on insurers case by case, says Buch

FRANKFURT (Reuters) – The European Central Bank will apply a favourable regulatory treatment of banks’ insurance holdings on a “case by case” basis, the ECB’s top supervisor Claudia Buch said on Tuesday.

The so-called Danish compromise, which reduces the cost in terms of capital for banks to own an insurer, is key to a number of proposed deals, including BNP Paribas (OTC:BNPQY)’s bid for AXA Investment Managers and Banco BPM’s offer for Anima Holding.

The use of the Danish compromise makes the acquisition of a fund manager, such as AXA IM or Anima, much cheaper for the buyers in terms of the hit to their regulatory capital.

The compromise lets banks risk-weigh their insurance investments instead of deducting them in full from their capital.

Both deals rely on an extensive interpretation of the Danish compromise which bankers and analysts said ignited a chain reaction in Europe’s financial sector in terms of potential mergers and acquisitions.

“We currently have under consultation a new guide that clarifies our approach there but at the end it’s also an issue that we would also assess on a case by case basis for individual institutions,” Buch told a news conference.

The ECB has launched a consultation over its regulation on how to apply options and discretions available in the European Union law.

The Danish compromise was introduced during the Danish EU presidency more than a decade ago to temporarily offset tough ‘Basel’ rules for European banks with insurance businesses.

In April the EU parliament approved regulation that makes the Danish compromise permanent. A regulatory clarification later indicated that the favourable treatment could apply not only to insurance businesses held by banks, but also to assets those banks buy through their insurance units.

However, the ECB has the final say in the matter.

BNP is carrying out the AXA IM acquisition through its insurance business BNP Paribas Cardif. Banco BPM has bid for Anima through its insurance unit Banco BPM Vita.

Mediobanca (OTC:MDIBY) Securities analyst Andrea Filtri calculated that the 5-billion-euro ($5.25 billion) AXA IM deal, without the Danish compromise, would cost BNP Paribs 65 basis points of capital instead of just 25 bps.

“The once-a-forbidden-dream is now reality, opening a new horizon for M&A,” Filtri said.

($1 = 0.9527 euros)

This post appeared first on investing.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    Economy

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com